A study shows elevated CFHR1 promotes immune complex buildup in kidneys, offering insights into disease mechanisms, enabling ...

Omeros Corporation (NASDAQ:OMER) Q4 2025 Earnings Call Transcript April 1, 2026 Operator: Good afternoon, and welcome to today’s earnings call for Omeros Corporation. [Operator Instructions] Please be ...

The ongoing GARDian3 study is designed to assess whether a single subretinal administration of OCU410ST can slow structural ...

Most CPG budgets now need a provable path to purchase, not just reach. The challenge is GCC fragmentation. Retail media, ...

Your brain’s “stop eating” signal may come from an unexpected source. Researchers found that astrocytes—once thought to just support neurons—actually play a key role in controlling appetite. After a ...

Newer FDA-approved treatments for myasthenia gravis (MG) include FcRn blockers and complement inhibitors, which offer ...

GARDian3 trial enrollment and dosing completed (N=63) in less than nine monthsTopline results expected in 2Q27 with BLA to follow by ...

Q4 2025 Earnings Call March 31, 2026 4:30 PM EDTCompany ParticipantsGregory Demopulos - Co-Founder, Chairman, CEO ...

This article argues for the adoption of a combined lyophilized plasma and platelet product strategy to address critical gaps.

In an era where blood-sugar supplements flood the market with exaggerated promises, Gluco Armor stands out for an ...

When your stomach is full, how does your brain know to stop eating?Scientists long assumed the answer lies mainly with neurons, the brain's primary ...

A collaborative research group has shown that biological neurons can be trained to perform a temporal pattern learning task ...